Fundraising Fox

Monte Rosa Therapeutics

NASDAQ: GLUE

Boston, US · Founded 2019 · Delaware corporation · 6 known investors

monterosatx.com ↗
Biotechin /monte-rosa-therapeutics@MonteRosaTx

Founders & leadership

AM
Alexander MaywegDirector
BB
Bradley BolzonDirector
MW
Markus WarmuthExecutive Officer, Director
AB
Ali BehbahaniDirector
KB
Kim BlackwellDirector

Investors · 6

Aisling CapitalNew York
Amzak HealthNew York
Avoro Capital AdvisorsNew York
GV (Google Ventures)Mountain View · $250K – $50M
Versant VenturesSan Francisco · $250K – $5M
Dimension CapitalreportedSan Francisco · $1M – $10M

Reported raises · per SEC filings

Form D private placements
▶$95MraisedMar 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Markus WarmuthExecutive Officer, Director
  • Alexander MaywegDirector
  • Bradley BolzonDirector
  • Ali BehbahaniDirector
  • Kim BlackwellDirector
  • Drew SchiffDirector
  • Chandra P. LeoDirector
  • Christine SiuDirector
  • Ajim TamboliExecutive Officer
Offering amount
$95M
Amount sold
$95M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48MraisedSep 2020 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander MaywegDirector
  • Bradley BolzonDirector
  • Markus WarmuthExecutive Officer, Director
  • Ali BehbahaniDirector
  • Kim BlackwellDirector
Offering amount
$96M
Amount sold
$48M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.